Bausch Health Co. Inc. (BHC) Misses Q2 EPS by $1.29

Bausch Health Co. Inc. (NYSE: BHC) reported Q2 EPS of ($0.40), $1.29 worse than the analyst estimate of $0.89. Revenue for the quarter came in at $1.97 billion versus the consensus estimate of $2.03 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2022 revenue of $8.05-8.22 billion, versus the consensus of $8.34 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• NexPoint Residential Trust (NXRT) PT Lowered to $26 at Truist Securities
• AeroVironment (AVAV) PT Lowered to $280 at Canaccord